SCHEMBL14905942

SCHEMBL14905942

CNNNCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8002040 0.80
SCHEMBL6284366 0.79
SCHEMBL23731655 0.73
SCHEMBL284681 0.71
SCHEMBL10904378 0.71
SCHEMBL16672175 0.71
SCHEMBL22131014 0.69
Hydrochloric Acid SCHEMBL28112622 0.68 KDM4E (0.53)
Hydrochloric Acid SCHEMBL10804922 0.68 KDM4E (0.53)
SCHEMBL27586898 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220025397-A1 LIGAND-DIRECTED TARGETING VECTORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-01-27 US disclosed
US-8476308-B2 GPR120 receptor agonists and uses thereof METABOLEX, INC. (US) 2013-07-02 US disclosed
US-20130131351-A1 GPR120 RECEPTOR AGONISTS AND USES THEREOF METABOLEX, INC. (US) 2013-05-23 US disclosed
US-20130109734-A1 GPR120 RECEPTOR AGONISTS AND USES THEREOF METABOLEX, INC. (US) 2013-05-02 US disclosed